Medical News
Latest News
Contact Us
Optimized Gmp-Grade Wharton’s Jelly’s Mesenchymal Stromal Cells Manufacturing and Administration Protocol for Graft Versus Host Disease Prevention
26/06/2025
SSRN, 20 May 2025 Mesenchymal stromal cells derived from Wharton’s jelly (WJ-MSCs) are multipotent cells originating from the umbilical cord, possessing strong immunomodulatory properties. These
Pooling umbilical cord-mesenchymal stromal cells derived from selected multiple donors reduces donor-dependent variability and improves their immunomodulatory properties
23/06/2025
Stem Cell Research & Therapy, 20/05/2025 A groundbreaking study published by Miryam Mebarki and colleagues in the journal Stem Cell Research & Therapy has demonstrated
hUC-MSCs loaded collagen scaffold for refractory thin endometrium caused by Asherman syndrome: a double-blind randomized controlled trial
19/06/2025
Pubmed Central, May 15, 2025 A double-blind randomized clinical trial conducted by Zhaojuan Hou and colleagues at Xiangya Hospital, Central South University, evaluated the efficacy
How Can the Placenta Help Us Understand Cancer?
16/06/2025
The Scientist, May 14, 2025 Like cancer, placental cells multiply rapidly, invade tissues, and evade destruction by the immune system, but maternal biology somehow keeps
Neonatal factors impacting umbilical cord blood unit characteristics
12/06/2025
Nature, May 14, 2025 A study published in Scientific Reports by Nature (2025) has shed light on the role of neonatal factors in determining the
Cell therapy with placenta-derived mesenchymal stem cells for secondary progressive multiple sclerosis patients in a phase 1 clinical trial
09/06/2025
Nature, 08/05/2025 A phase 1 clinical trial conducted by researchers at Tehran University of Medical Sciences evaluated the safety and feasibility of placenta-derived mesenchymal stem
Successful treatment of very severe aplastic anemia with double unrelated umbilical cord blood transplantation in a donor-specific antigen positive adult patient: A case report and review
05/06/2025
ScienceDirect, May 2025 A recent study published in Transplant Immunology (2025) reported the successful treatment of an adult patient with very severe aplastic anemia (VSAA)
Novel method enables safe delivery of stem cells in critically ill patients on external lung support
28/05/2025
Medical Xpress, April 16 2025 Mesenchymal stromal cells (MSCs) are delivered directly into the lungs using a bronchoscope (CIBA method), where they migrate through the
Sequential Infusion of Mesenchymal Stem Cell for Graft-Versus-Host Disease Prevention in Haploidentical Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized Controlled Clinical Trial
26/05/2025
Journal of Clinical Oncology, April 15, 2025 Abstract A multicenter, randomized clinical trial conducted in China demonstrated that sequential infusion of umbilical cord–derived mesenchymal stem
Therapeutic Potential of Mesenchymal Stem Cells in Stroke Treatment
22/05/2025
Biomolecule, 10 April 2025 Background Stroke is a leading cause of death and disability worldwide, with ischemic stroke accounting for up to 87% of all
